Purchases and Sales Made in Q2 2023 in Mainz Biomed N.V. (MYNZ)
This table provides information about the institutional ownership of Mainz Biomed N.V. (MYNZ) during Q2 2023. The information is specifically focused on institutions that hold shares of MAINZ BIOMED N.V..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Greenwich Investment Management, Inc.
Stamford, CT |
BUY
|
- |
14.2KNew |
$48.4K - $91.9K
|
14.2K
$3.54K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
200New |
$684 - $1.3K
|
200
$50
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
100New |
$342 - $649
|
100
$25
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
14New |
$47.9 - $90.9
|
14
$3.5
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-1.27K- 57.76% |
$4.35K - $8.26K
|
931
$233
|